These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation. Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468 [TBL] [Abstract][Full Text] [Related]
10. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts. Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154 [TBL] [Abstract][Full Text] [Related]
11. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome. Gaspard GJ; McMaster CR Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690 [TBL] [Abstract][Full Text] [Related]
12. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation. Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899 [TBL] [Abstract][Full Text] [Related]
13. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells. Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome. de Taffin de Tilques M; Tribouillard-Tanvier D; Tétaud E; Testet E; di Rago JP; Lasserre JP Dis Model Mech; 2017 Apr; 10(4):439-450. PubMed ID: 28188263 [TBL] [Abstract][Full Text] [Related]
16. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome. Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974 [TBL] [Abstract][Full Text] [Related]
17. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome. Zhang J; Liu X; Nie J; Shi Y Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382 [TBL] [Abstract][Full Text] [Related]
19. Loss of Mitochondrial Ca Bertero E; Nickel A; Kohlhaas M; Hohl M; Sequeira V; Brune C; Schwemmlein J; Abeßer M; Schuh K; Kutschka I; Carlein C; Münker K; Atighetchi S; Müller A; Kazakov A; Kappl R; von der Malsburg K; van der Laan M; Schiuma AF; Böhm M; Laufs U; Hoth M; Rehling P; Kuhn M; Dudek J; von der Malsburg A; Prates Roma L; Maack C Circulation; 2021 Nov; 144(21):1694-1713. PubMed ID: 34648376 [TBL] [Abstract][Full Text] [Related]
20. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome. Petit PX; Ardilla-Osorio H; Penalvia L; Rainey NE Cells; 2020 Oct; 9(10):. PubMed ID: 33096711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]